Skip to main navigation menu Skip to main content Skip to site footer

Asthma in pregnancy

Asma en el embarazo




Section
Topics review

How to Cite
Asthma in pregnancy.
rev. colomb. neumol. [Internet]. 2015 Jul. 20 [cited 2024 Nov. 21];27(3). Disponible en: https://doi.org/10.30789/rcneumologia.v27.n3.2015.82

Dimensions
PlumX
license

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Clara Patricia García

    Clara Patricia García,

    Internista, Neumóloga, Hospital Pablo Tobón Uribe, Neumóloga Fundación Antioqueña de Infectología, Laboratorio de Función Pulmonar. Medellín, Colombia. Docente Honorario Universidad Tecnológica de Pereira, Colombia.

    Asthma is a condition that can appear during pregnancy. It is impossible to predict whether asthma will worsen, remain the same, or improve during pregnancy. It is clear that total control of symptoms is necessary to prevent complications, which can often appear during pregnancy due to gestational physiological changes. It is important to be acquainted with the physiological changes, the diagnostic tests, and the methods for assessing the control of the disease. It is likewise important to know the risks associated with treating and not treating women with asthma during pregnancy.

    This review covers these subjects in order to increase the knowledgeability of all healthcare professionals who manage this group of patients. 


    Article visits 1686 | PDF visits 12673


    Downloads

    Download data is not yet available.
    1. Weinberger SE, Schatz M. Physiology and clinical course of asthma in pregnancy (internet). (place unknown). 2016. (updated 2016 Feb) Disponible en: http://www.uptodate.com/ home
    2. Murphy VE, Gibson PG. Asthma in Pregnancy. Clin Chest Med. 2011;32:93-110.
    3. Tamasi L, Bohacs A, Tamasi V, Stenczer B, Prohászka Z, Rigó J Jr, et al. Increased circulating heat shock protein 70 levels in pregnant asthmatics. Cell Stress Chaperones. 2010;15:295.
    4. Hardy-Fairbanks AJ, Baker ER. Asthma in pregnancy: pathophysiology, diagnosis and management. Obstet Gynecol Clin N Am. 2010;37:159–72.
    5. Schatz M, Leibman C. Inhaled corticosteroid use and outcomes in pregnancy. Ann Allergy Asthma Immunol. 2005;95:234.
    6. Murphy VE, Gibson P, Talbot PI, et al. Severe asthma exacerbations during pregnancy. Obstet Gynecol. 2005; 106:104654.
    7. Stenius-Aarniala BS, Hedman J, Teramo KA. Acute asthma during pregnancy. Thorax. 1996;51:411.
    8. Schatz M, Leibman C. Inhaled corticosteroid use and outcomes in pregnancy. Ann Allergy Asthma Immunol. 2005;95:234.
    9. Graves C. Pneumonia in pregnancy. Obstet Gynecol. 2010;53 (2):329–36.
    10. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004; 113:59-65.
    11. Monteiro M, Rizzo JA, de Melo Junior EF, Pires Lins ESLME, et al. Validation of the Asthma Control Test in pregnant asthmatic women. Respir Med. 2014;108:1589-93.
    12. Palmsten K, Schatz M, Chan PH, et al. Validation of the pregnancy asthma control test. J allergy Clin Immunol Pract. 2015; 4(2):310-5.
    13. Garne E, Hansen AV, Morris J, et al. Use of asthma medication during pregnancy and risk of specific congenital anomalies: A European case-malformed control study. J Allergy Clin Immunol. 2015;136:1496.
    14. Eltonsy S, Forget A, Beauchesne MF, Blais L. Risk of congenital malformations for asthmatic pregnant women using a long-acting β2-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy. J Allergy Clin Immunol. 2015;135:123.
    15. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62:385.
    16. Schatz M, Dombrowski MP, Wise R, et al. The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol. 2004;113:1040.
    17. Källén B, Rydhstroem H, Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol. 1999;93:392.
    18. Charlton RA, Snowball JM, Neghtingale AL, Davis KJ. Prescribed for Asthma During Pregnancy: A UK Population-Based Cohort Study. J Allergy Clin Immunol Pract. 2015;3:772.
    19. Blais L, Beauchesne MF, Lemière C, Elftouh N. High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations. J Allergy Clin Immunol. 2009;124:1229.
    20. Wendel PJ, Ramin SM, Barnett-Hamm C, et al. Asthma treatment in pregnancy: a randomized controlled study. Am J Obstet Gynecol. 1996;175:150.
    21. Hirashima J, Hojo M, Iikura M. A case of an asthma patient receiving omalizumab during pregnancy. Arerugi. 2012;61(11):1683-7.
    22. Namazy J, Cabana MD, Scheuerle AE. The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy. J Allergy Clin Immunol. 2015;135(2):407-12.
    Sistema OJS 3.4.0.7 - Metabiblioteca |